Breaking News Instant updates and real-time market news.

TNDM

TNDM

06:04
11/21/18
11/21
06:04
11/21/18
06:04

Tandem Diabetes upgraded to Outperform from Neutral at Baird

  • 27

    Nov

TNDM TNDM

11/12/18
PIPR
11/12/18
NO CHANGE
PIPR
Piper continues to like pure play diabetes stocks after conference
Piper Jaffray analyst JP McKim left this weekend's Diabetes Technology Meeting feeling that DexCom (DXCM) "has a lot in its pipeline" and remains a few steps ahead of the competition, Insulet (PODD) is having "great success" in the pharmacy and is on the forefront of cybersecurity, and Tandem Diabetes (TNDM) remains in a "strong position to take market share." The analyst continues to like pure play diabetes names and keeps an Overweight rating on all three names.
11/09/18
OPCO
11/09/18
NO CHANGE
Target $57
OPCO
Outperform
Insulin pump renewals to become important tailwind for Tandem, says Oppenheimer
Oppenheimer analyst Steve Lichtman reiterated an Outperform rating and $57 price target on Tandem Diabetes Care (TNDM), telling investors in a research note that he believes insulin pump renewals will become an increasingly important tailwind to the Tandem business over the next couple of years. Year-to-date, he estimates Tandem captured greater than55% of potential renewals with durable pumps having four year warranties, at which point insurance typically covers a new pump. Lichtman says pipeline ramp and OUS remain potential upside drivers as does the potential for coverage reinstatement by UnitedHealth (UNH).
11/02/18
LSCM
11/02/18
NO CHANGE
Target $60
LSCM
Buy
Lake Street affirms $60 target on Tandem Diabetes after Q3 results
Tandem Diabetes' "strong momentum" continued during Q3 as revenue growth accelerated from 43.7% in Q1 to 60.0% in Q2 and 71.3% during Q3, Lake Street analyst Brooks O'Neil tells investors in a post-earnings research note. The analyst sees the strong results continuing into Q4 and affirms a buy rating on the shares with a $60 price target.
11/02/18
CHLM
11/02/18
NO CHANGE
Target $59
CHLM
Buy
Tandem Diabetes on path to post Q4 revenue of $65M, says Craig-Hallum
Craig-Hallum analyst Alexander Nowak reiterated a Buy rating and $59 price target on Tandem Diabetes after the company beat already pre-announced Q3 sales and raised 2018 guidance. In a research note to investors, Nowak says he still sees multiple reasons why estimates will keep moving higher and believes Q3 is another example of "excellent execution in the face of solid trends" and expects similar performance in Q4. Nowak raised his estimates to the upper-end of the implied Q4 guidance range, but sees a path for Tandem to ultimately post Q4 revenue of $65M.

TODAY'S FREE FLY STORIES

XRX

Xerox

$21.25

-0.02 (-0.09%)

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Options
Xerox call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

BPMUF

Basilea Pharmaceutica

$0.00

(0.00%)

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Conference/Events
Cantor Fitzgerald pharma analysts to hold an analyst/industry conference call »

Pharmaceuticals analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

12:25
12/18/18
12/18
12:25
12/18/18
12:25
Conference/Events
Federal Reserve Board to hold a closed meeting »

The Federal Reserve holds…

GM

General Motors

$35.20

0.54 (1.56%)

12:23
12/18/18
12/18
12:23
12/18/18
12:23
Periodicals
GM to cut 50 jobs at Detroit lithium-ion battery assembly plant, Reuters reports »

General Motors will cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVH

PVH Corp.

$93.27

1.92 (2.10%)

12:21
12/18/18
12/18
12:21
12/18/18
12:21
Hot Stocks
PVH Corp. CEO Chirico acquires 10,000 shares for $95.51 »

PVH Corp. CEO Emanuel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
12/18/18
12/18
12:17
12/18/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
12/18/18
12/18
12:16
12/18/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOXO

XO Group

$35.00

0.015 (0.04%)

12:12
12/18/18
12/18
12:12
12/18/18
12:12
Hot Stocks
XO Group shareholders approve merger with WeddingWire »

XO Group announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:07
12/18/18
12/18
12:07
12/18/18
12:07
Hot Stocks
DOJ says Germany's IAV GmbH to Pay $35M fine for role in VW emissions fraud »

IAV GmbH, IAV, a German…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$24.00

0.78 (3.36%)

12:05
12/18/18
12/18
12:05
12/18/18
12:05
Options
DSW call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$19.06

-2.36 (-11.02%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Luxfer falls -10.9% »

Luxfer is down -10.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

BPT

BP Prudhoe Bay

$22.75

-2.745 (-10.77%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
BP Prudhoe Bay falls -11.2% »

BP Prudhoe Bay is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$81.94

-11.81 (-12.60%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -12.4% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWT

Britannia Bulk

$16.08

1.7 (11.82%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Britannia Bulk rises 11.7% »

Britannia Bulk is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$81.37

8.68 (11.94%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 11.9% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$26.90

3.06 (12.84%)

12:00
12/18/18
12/18
12:00
12/18/18
12:00
Hot Stocks
Navistar rises 12.8% »

Navistar is up 12.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VLKAY

Volkswagen

$0.00

(0.00%)

11:57
12/18/18
12/18
11:57
12/18/18
11:57
Periodicals
Volkswagen seen gaining edge in German test case, Bloomberg says »

Volkswagen will more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$84.00

-3.45 (-3.95%)

11:55
12/18/18
12/18
11:55
12/18/18
11:55
Options
Twilio put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

11:55
12/18/18
12/18
11:55
12/18/18
11:55
Conference/Events
RBC Capital retail-hardlines analyst to hold a group luncheon »

Retail/Hardlines Analyst…

ADTN

Adtran

$10.92

-0.05 (-0.46%)

11:51
12/18/18
12/18
11:51
12/18/18
11:51
Earnings
Adtran announces CAF II solutions to address rural U.S. areas without broadband »

Adtran announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
12/18/18
12/18
11:50
12/18/18
11:50
General news
FX Action: USD-CAD »

FX Action: USD-CAD has…

FB

Facebook

$143.24

2.93 (2.09%)

11:47
12/18/18
12/18
11:47
12/18/18
11:47
Hot Stocks
Facebook COO Sandberg says needs to step up efforts to curb misinformation »

Facebook COO Sheryl…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMT

American Tower

$162.39

1.47 (0.91%)

11:45
12/18/18
12/18
11:45
12/18/18
11:45
Conference/Events
American Tower management to meet with SunTrust »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

, ENDP

Endo

$9.45

(0.00%)

11:43
12/18/18
12/18
11:43
12/18/18
11:43
Hot Stocks
Catalyst Pharmaceuticals, Endo sign definitive agreement for vigabatrin tablets »

Catalyst Pharmaceuticals…

CPRX

Catalyst Pharmaceuticals

$2.43

0.085 (3.62%)

ENDP

Endo

$9.45

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$17.39

-0.26 (-1.47%)

11:40
12/18/18
12/18
11:40
12/18/18
11:40
Options
Put buyer in Teva Pharmaceuticals appears to adjust week-old position »

Put buyer in Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.